Top Markets
#1 Wrapped STX (Velar) Wrapped STX (Velar) +40.12%
#2 aelf aelf +31.86%
#3 Bitway Bitway +30.02%
#4 FGRS (Figure Tokenized Stock) FGRS (Figure Tokenized Stock) +23.94%
#5 Pons Pons +23.34%
#6 Starpower Starpower +22.55%
#7 Decred Decred +14.50%
#8 PondCoin PondCoin +10.22%
#9 Talus Network Talus Network +8.58%
#10 DAPPOS DAPPOS +8.37%
Coin of the day
Wrapped STX (Velar) Wrapped STX (Velar)
Einstellungen
Sprache
DEUTSCH
Währung
USD
Thema
Tvardi Therapeutics, Inc. Tvardi Therapeutics, Inc.

Tvardi Therapeutics, Inc.

TVRD
Rang in Aktien #30251
Tvardi Therapeutics, Inc., a clinical-stage biopharmaceutical company, engages... Tvardi Therapeutics, Inc., a clinical-stage biopharmaceutical company, engages in the development of novel, oral, and small molecule therapies targeting signal transducer and activator of transcription 3 (STAT3) to treat inflammatory and proliferative diseases with significant unmet need in the United States. The company's lead product candidates include TTI-101, which is in Phase 1b/2 clinical development stage for fibrosis-driven diseases with an initial focus on idiopathic pulmonary fibrosis (IPF), and hepatocellular carcinoma (HCC); and TTI-109, an oral, small molecule STAT3 inhibitor which is in Phase-1 clinical trial stage. Tvardi Therapeutics, Inc. was founded in 2017 and is based in Sugar Land, Texas.
Aktienkurs
$1.88
Zuletzt synchronisiert: 2026-08-18
Marktkapitalisierung
$17.59M
Veränderung (1 Tag)
0.81%
Veränderung (1 Jahr)
-92.40%
Land
US
Handel Tvardi Therapeutics, Inc. (TVRD)

Kategorie

Healthcare
Kursverlauf für Tvardi Therapeutics, Inc. (TVRD)
Höchster Schlusskurs: $1.83 am 2026-08-01

Niedrigster Schlusskurs: $17.54 am 2025-04-01
Kursverlauf der Aktie von Tvardi Therapeutics, Inc. von 2025 bis 2026
Jährliche Kursentwicklung
Jahr Leistung
2026 (TTM) 100.99%
2025 0.00%
Aktienkurs vergleichbarer Unternehmen oder Wettbewerber
Unternehmen Aktienkurs Veränderung 1J% Land
Vertex Pharmaceuticals Incorporated Vertex Pharmaceuticals Incorporated
Vertex Pharmaceuticals Incorporated
VRTX.US
 $527.89 35.09%
US
Argenx SE Argenx SE
Argenx SE
ARGX.US
 $996.61 51.72%
NL
CSL Limited CSL Limited
CSL Limited
CSL.AX
 $116.89 -19.70%
AU
Lonza Group AG Lonza Group AG
Lonza Group AG
LONN.SW
 $735.86 6.07%
CH
Samsung Biologics Co.,Ltd. Samsung Biologics Co.,Ltd.
Samsung Biologics Co.,Ltd.
207940.KS
 $1.06K -6.19%
KR